Evaluation of Gelatinolytic and Collagenolytic Activity of Fasciola hepatica Recombinant Cathepsin-L1.

Cathepsin L1 Collagen Fasciola hepatica Gelatin Recombinant enzyme

Journal

Iranian journal of biotechnology
ISSN: 1728-3043
Titre abrégé: Iran J Biotechnol
Pays: Iran
ID NLM: 101276796

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

Cysteine proteases of the liver fluke, Fasciola hepatica, participate in catabolism of proteins, migration of the fluke through host tissues and combat host immune system. In this study, we evaluated proteolytic activity of F. hepatica recombinant cathepsin L1 (rCL1) against gelatin and collagen as common substrates. The coding sequences of F. hepatica CL1 were cloned and expressed in E. coli, in our previous study. The rCL1 was purified by nickel affinity chromatography with a HisTrap Column. The protein concentrations of the purified fractions were determined by Bradford assay. Rat collagen type-1 was treated with distinct amounts of rCL1 at 37 °C, overnight, and the byproduct was analyzed by SDS-PAGE. Furthermore, we used bovine skin gelatin as zymography substrate to evaluate the gelatinolytic activity of the purified rCL1. Recombinant CL1 was capable to digest intact type-1 collagen within 24 h and the gelatinlytic activity of rCL1 was visible at approximately 37 kDa region, with optimal activity at acidified conditions (pH 4). Findings provide a possible mechanism by which a major secretory molecule of F. hepatica could be involved in parasite survival as well as its pathogenesis.

Sections du résumé

BACKGROUND BACKGROUND
Cysteine proteases of the liver fluke, Fasciola hepatica, participate in catabolism of proteins, migration of the fluke through host tissues and combat host immune system.
OBJECTIVES OBJECTIVE
In this study, we evaluated proteolytic activity of F. hepatica recombinant cathepsin L1 (rCL1) against gelatin and collagen as common substrates.
MATERIAL AND METHODS METHODS
The coding sequences of F. hepatica CL1 were cloned and expressed in E. coli, in our previous study. The rCL1 was purified by nickel affinity chromatography with a HisTrap Column. The protein concentrations of the purified fractions were determined by Bradford assay. Rat collagen type-1 was treated with distinct amounts of rCL1 at 37 °C, overnight, and the byproduct was analyzed by SDS-PAGE. Furthermore, we used bovine skin gelatin as zymography substrate to evaluate the gelatinolytic activity of the purified rCL1.
RESULTS RESULTS
Recombinant CL1 was capable to digest intact type-1 collagen within 24 h and the gelatinlytic activity of rCL1 was visible at approximately 37 kDa region, with optimal activity at acidified conditions (pH 4).
CONCLUSION CONCLUSIONS
Findings provide a possible mechanism by which a major secretory molecule of F. hepatica could be involved in parasite survival as well as its pathogenesis.

Identifiants

pubmed: 32884958
doi: 10.30498/IJB.2020.143160.2357
pii: IJB-18-1
pmc: PMC7461709
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2357

Informations de copyright

Copyright: © 2019 The Author(s); Published by Iranian Journal of Biotechnology.

Références

PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2414
pubmed: 24069474
Mol Cell Proteomics. 2008 Jun;7(6):1111-23
pubmed: 18296439
Iran J Allergy Asthma Immunol. 2004 Mar;3(1):7-11
pubmed: 17301385
Nature. 1966 Feb 12;209(5024):713-4
pubmed: 4288463
Exp Parasitol. 2000 Feb;94(2):75-83
pubmed: 10673343
Trans R Soc Trop Med Hyg. 2016 Sep;110(9):542-550
pubmed: 27794095
Am J Trop Med Hyg. 1999 May;60(5):749-51
pubmed: 10344647
Mol Biochem Parasitol. 2009 Sep;167(1):41-7
pubmed: 19383516
Infect Immun. 1999 Oct;67(10):5372-8
pubmed: 10496919
Iran J Allergy Asthma Immunol. 2007 Sep;6(3):107-14
pubmed: 17893430
Trends Biochem Sci. 2008 Dec;33(12):601-8
pubmed: 18848453
Parasite Immunol. 2001 Oct;23(10):541-7
pubmed: 11696165
Korean J Parasitol. 2005 Mar;43(1):33-7
pubmed: 15793357
Infect Immun. 1996 Apr;64(4):1328-34
pubmed: 8606097
PLoS Negl Trop Dis. 2012;6(7):e1680
pubmed: 22802972
Eur J Biochem. 1994 Jul 1;223(1):91-8
pubmed: 8033913
J Biol Chem. 2004 Apr 23;279(17):17038-46
pubmed: 14754899
Vet Parasitol. 2015 Feb 28;208(1-2):101-11
pubmed: 25657086
Exp Parasitol. 2001 Aug;98(4):223-7
pubmed: 11560415
Adv Parasitol. 2009;69:41-146
pubmed: 19622408
Bioinformatics. 2001 Dec;17(12):1244-5
pubmed: 11751241

Auteurs

Kobra Mokhtarian (K)

Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Reza Falak (R)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.

Zahra Heidari (Z)

Department of Medical Parasitology, School of Medicine, Ardabil University of Medical Sciences.

Classifications MeSH